Prof Mukhopadhyay from IIT-B among 3 Indian scientists chosen for Tata Transformation Prize
Amartya Mukhopadhyay's battery prototype is approximately 30 per cent cheaper than lithium-ion batteries, operates in a broader temperature range, and is safer to store by creating air-and water-stable sodium-transition metal oxide cathodes and alloy-based anodes.
2 min read
Mukhopadhyay is working to advance sodium-ion battery technologies through recent breakthroughs in materials science. (File Photo)Professor Amartya Mukhopadhyay from the Indian Institute of Technology (IIT) Bombay is among three scientists from India selected as winners of 2024 edition of the Tata Transformation Prize.
While Mukhopadhyay has been selected in the Sustainability category; other two winners are – C Anandharamakrishnan, PhD from CSIR–National Institute for Interdisciplinary Science and Technology, who was selected in the category of Food Security, and Raghavan Vardadarajan, PhD from Indian Institute of Science in Bengaluru, awarded in the Healthcare category.
Each winner will receive Rs 2 crore (approximately $240,000) and will be honored at a ceremony in Mumbai in December 2024, announced Tata Sons and the New York Academy of Sciences, on Monday.
The Tata Transformation Prize was established in 2022 by Tata Sons, and is powered by the NYAS, to support innovative technologies that address India’s most significant challenges.
The three scientists were selected from 169 entries from 18 Indian states by an international jury of leading experts including distinguished scientists, clinicians, technologists, and engineers from a diverse array of industries, government, and academic institutions.
The winners’ works
Mukhopadhyay is working to advance sodium-ion battery technologies through recent breakthroughs in materials science.
His battery prototype is approximately 30 per cent cheaper than lithium-ion batteries, operates in a broader temperature range, and is safer to store by creating air-and water-stable sodium-transition metal oxide cathodes and alloy-based anodes.
Anandharamakrishnan has pioneered a variety of rice fortified with multiple essential nutrients that simultaneously has a low glycemic index (GI) to control blood sugar levels in diabetics. He has developed advanced food technologies such as a three-fluid nozzle spray drying process to efficiently encapsulate and deliver these nutrients in reconstituted rice.
Dr. Raghavan is working to develop a cost-effective Respiratory Syncytial Virus (RSV) vaccine which will provide broad and longer-lasting protection against RSV infection which causes severe respiratory illness.
You May Like
Photos
